Skip to content

Avanos Medical AVNS Shares (Basic)

Shares (Basic) at other companies

Stryker logo
StrykerSYK
382.9M+0.3%
Cardinal Health logo
Cardinal HealthCAH
235M-2.1%
Boston Scientific logo
Boston ScientificBSX
1.5B+0.5%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
40.5M-12.6%
Medtronic logo
MedtronicMDT
1.3B-0.3%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
32.1M+0.9%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's shares (basic)?
Avanos Medical (AVNS) reported shares (basic) of 46.5M in Q1 2026.
How has Avanos Medical's shares (basic) changed year-over-year?
Avanos Medical's shares (basic) increased by 0.9% year-over-year, from 46.1M to 46.5M.
What is the long-term trend for Avanos Medical's shares (basic)?
Over 4 years (2021 to 2025), Avanos Medical's shares (basic) has grown at a -0.9% compound annual growth rate (CAGR), from 192.3M to 185.1M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.